Invest now

Shilpa Medicare Profit & Loss Annual

BSE: 530549 | NSE: SHILPAMED | ISIN: INE790G01031 | Sector: Biotechnology & Drugs
944.00 -20.95 (-2.17%)Updated : 07 Sep 2026
Research on
Fiscal Period2026202520242023
Period End DateMar 26Mar 25Mar 24Mar 23
Total Operating Expense 1,302.371,123.281,017.811,057.08
Other Net -4.69-40.53-42.8812.37
Diluted Weighted Average Shares 19.5619.4917.3617.36
Gain( Loss)on Saleof Assets 4.66-0.270.54-0.26
Depreciation/ Amortization 119.72112.99107.8795.50
Operating Income 236.50163.13133.79-6.96
Net Income 243.3378.2931.87-32.48
Income Availableto Com Excl Extra Ord 243.3378.2931.87-32.48
Other Operating Expenses Total 21.8918.6016.4519.06
Net Income Before Taxes 295.32122.3354.34-38.28
Minority Interest 0.000.00-0.08-1.56
Net Income After Taxes 243.3378.3031.96-30.92
Income Availableto Com Incl Extra Ord 243.3378.2931.87-32.48
Costof Revenue Total 534.77478.52473.70487.10
Gross Profit 1,004.10807.90677.90563.01
Interest Inc( Exp) Net- Non- Op Total 58.850.00-37.12-43.42
Unusual Expense( Income) 24.9430.58-6.130.00
Diluted Net Income 243.3378.2931.87-32.48
DPS- Common Stock Primary Issue 0.600.50-0.00
Provisionfor Income Taxes 51.9944.0422.39-7.36
period Type ----
Net Income Before Extra Items 243.3378.2931.87-32.48
Total Revenue 1,538.871,286.411,151.601,050.11
period Length 12.0012.0012.0012.00
Revenue 1,538.871,286.411,151.601,050.11
Selling/ General/ Admin Expenses Total 539.81434.22394.97406.32
Diluted Normalized EPS 13.305.031.61-1.86
Research Development 61.2448.3730.9649.10
Diluted EPS Excluding Extra Ord Items 12.444.021.84-1.87
Total Adjustmentsto Net Income -0.00--
*All figures in crores except per share values
Recommended For You
Trending Stocks
1,266.15+11.15(0.89%)
2,540.00+13.30(0.53%)
4,960.00-110.00 (-2.17%)
2,807.35-55.15 (-1.93%)